Probiotic neoantigen delivery vectors for precision cancer immunotherapy - Nature
www.nature.com
Probiotic Escherichia coli Nissle 1917 is engineered as an antitumour vaccination platform optimized for enhanced production and cytosolic delivery of neoepitope-containing peptide arrays to safely induce specific, effective and durable systemic antitumour immunity.
  • AGD4@lemmy.world
    1·
    1 month ago

    This all sounds interesting and very complex, but I believe it is misplaced in a ‘Nature’ community. Particularly with statements like:

    synthetically engineered to deploy therapeutic payloads